• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

野生型转甲状腺素蛋白淀粉样心肌病患者深呼吸负荷下R-R间期变异性系数:一项病例对照研究。

Coefficient of R-R interval variations under deep breathing load in patients with wild-type transthyretin amyloid cardiomyopathy: A case-control study.

作者信息

Nagayoshi Yasuhiro, Kawano Hiroaki, Nishihara Taiki, Morikawa Kei, Nagano Haruka, Hanatani Shinsuke, Sakaino Naritsugu, Tsujita Kenichi

机构信息

Department of Cardiology Amakusa Medical Center Amakusa Japan.

Department of Cardiovascular Medicine, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.

出版信息

Health Sci Rep. 2022 Nov 30;6(1):e938. doi: 10.1002/hsr2.938. eCollection 2023 Jan.

DOI:10.1002/hsr2.938
PMID:36467751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9710487/
Abstract

BACKGROUND AND AIMS

An autonomic nervous disorder is an important characteristic of cardiac amyloidosis; however, the prevalence of autonomic dysfunction in wild-type transthyretin amyloidosis (ATTR) has not been established. Analysis of the R-R interval coefficient of variation (CVR-R) is a noninvasive method to measure parasympathetic activity. We aimed to assess autonomic dysfunction of ATTR and determine the utility of CVR-R for the detection of ATTR in other cardiac diseases.

METHODS

This is a single-center, retrospective, case-control study. Fifty patients with heart failure (HF) were studied. The etiologies of HF were as follows: ATTR,  = 10; previous myocardial infarction (MI),  = 20; and left ventricular hypertrophy (LVH) due to other disease processes (e.g., aortic stenosis),  = 20. We measured the CVR-R at rest (CVR-R), CVR-R with deep breaths (CVR-R), and the change rate (CVR-R. The relative change formula is as follows: CVR-R = (CVR-R - CVR-R)/CVR-R  100 (%).

RESULTS

There was no difference in the CVR-R levels among the three groups. The CVR-R levels in the ATTR group were significantly lower (ATTR: -8.77 [-43.8 to 10.9]; LVH: 67.4 [38.7 to 89.4]; MI: 83.7 [60.4 to 142.9]). Based on the receiver operative characteristic curve analysis to identify ATTR in HF, the best cut-off value for the CVR-R was 19.7 (area under the curve: 0.848).

CONCLUSION

Our data suggested autonomic dysfunction in patients with ATTR. Measurement of the CVR-R in HF patients may be a convenient support tool for the detection of ATTR.

摘要

背景与目的

自主神经功能紊乱是心脏淀粉样变性的一个重要特征;然而,野生型转甲状腺素蛋白淀粉样变性(ATTR)中自主神经功能障碍的患病率尚未确定。RR间期变异系数(CVR-R)分析是一种测量副交感神经活动的非侵入性方法。我们旨在评估ATTR的自主神经功能障碍,并确定CVR-R在检测其他心脏疾病中的ATTR的效用。

方法

这是一项单中心、回顾性、病例对照研究。研究了50例心力衰竭(HF)患者。HF的病因如下:ATTR,=10;既往心肌梗死(MI),=20;以及其他疾病过程(如主动脉狭窄)导致的左心室肥厚(LVH),=20。我们测量了静息时的CVR-R(CVR-R)、深呼吸时的CVR-R(CVR-R)和变化率(CVR-R。相对变化公式如下:CVR-R =(CVR-R - CVR-R)/CVR-R×100(%)。

结果

三组之间的CVR-R水平没有差异。ATTR组的CVR-R水平显著较低(ATTR:-8.77[-43.8至10.9];LVH:67.4[38.7至89.4];MI:83.7[60.4至142.9])。基于用于识别HF中ATTR的受试者工作特征曲线分析,CVR-R的最佳截断值为19.7(曲线下面积:0.848)。

结论

我们的数据表明ATTR患者存在自主神经功能障碍。测量HF患者的CVR-R可能是检测ATTR的一种方便的辅助工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/984a/9710487/3ddcb2cff656/HSR2-6-e938-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/984a/9710487/d9107f4ff32b/HSR2-6-e938-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/984a/9710487/24f29d4ab4db/HSR2-6-e938-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/984a/9710487/b4da8ab5076a/HSR2-6-e938-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/984a/9710487/607c8317e80d/HSR2-6-e938-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/984a/9710487/3ddcb2cff656/HSR2-6-e938-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/984a/9710487/d9107f4ff32b/HSR2-6-e938-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/984a/9710487/24f29d4ab4db/HSR2-6-e938-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/984a/9710487/b4da8ab5076a/HSR2-6-e938-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/984a/9710487/607c8317e80d/HSR2-6-e938-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/984a/9710487/3ddcb2cff656/HSR2-6-e938-g003.jpg

相似文献

1
Coefficient of R-R interval variations under deep breathing load in patients with wild-type transthyretin amyloid cardiomyopathy: A case-control study.野生型转甲状腺素蛋白淀粉样心肌病患者深呼吸负荷下R-R间期变异性系数:一项病例对照研究。
Health Sci Rep. 2022 Nov 30;6(1):e938. doi: 10.1002/hsr2.938. eCollection 2023 Jan.
2
Reduced trans-mitral A-wave velocity predicts the presence of wild-type transthyretin amyloidosis in elderly patients with left ventricular hypertrophy.经二尖瓣A波速度降低可预测老年左心室肥厚患者野生型转甲状腺素蛋白淀粉样变性的存在。
Heart Vessels. 2017 Jun;32(6):708-713. doi: 10.1007/s00380-016-0925-8. Epub 2016 Nov 23.
3
Autonomic dysfunction in cardiac amyloidosis assessed by heart rate variability and heart rate turbulence.心脏淀粉样变的自主神经功能障碍评估:心率变异性和心率震荡。
Ann Noninvasive Electrocardiol. 2020 Jul;25(4):e12749. doi: 10.1111/anec.12749. Epub 2020 Feb 21.
4
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study.野生型转甲状腺素蛋白心脏淀粉样变在老年人群中并不罕见:CATCH 筛查研究。
Eur J Prev Cardiol. 2024 Aug 22;31(11):1410-1417. doi: 10.1093/eurjpc/zwae093.
5
Frailty in heart failure according to the presence or absence of wild-type transthyretin cardiac amyloidosis.根据野生型转甲状腺素蛋白心脏淀粉样变性的有无,探讨心力衰竭中的衰弱情况。
ESC Heart Fail. 2025 Feb;12(1):281-289. doi: 10.1002/ehf2.15026. Epub 2024 Sep 16.
6
Strain-derived myocardial work in wild-type transthyretin cardiac amyloidosis with aortic stenosis-diagnosis and prognosis.野生型转甲状腺素蛋白心脏淀粉样变性合并主动脉瓣狭窄时应变衍生心肌功的诊断与预后
Echocardiography. 2023 Oct;40(10):1079-1087. doi: 10.1111/echo.15681. Epub 2023 Aug 25.
7
EstimATTR: A Simplified, Machine-Learning-Based Tool to Predict the Risk of Wild-Type Transthyretin Amyloid Cardiomyopathy.EstimATTR:一种简化的、基于机器学习的工具,用于预测野生型转甲状腺素蛋白淀粉样心肌病的风险。
J Card Fail. 2024 Jun;30(6):778-787. doi: 10.1016/j.cardfail.2023.11.017. Epub 2023 Dec 7.
8
Use of Ventilatory Efficiency Slope as a Marker for Increased Mortality in Wild-Type Transthyretin Cardiac Amyloidosis.通气效率斜率作为野生型转甲状腺素蛋白心脏淀粉样变患者死亡率增加的标志物的应用。
Am J Cardiol. 2019 Jul 1;124(1):122-130. doi: 10.1016/j.amjcard.2019.03.035. Epub 2019 Apr 9.
9
Same same, but different? The neurological presentation of wildtype transthyretin (ATTRwt) amyloidosis.一样又不一样?野生型转甲状腺素蛋白(ATTRwt)淀粉样变的神经表现。
Amyloid. 2022 Jun;29(2):92-101. doi: 10.1080/13506129.2021.2014448. Epub 2022 Jan 7.
10
Determining patterns of vascular function and structure in wild-type transthyretin cardiac amyloidosis. A comparative study.确定野生型转甲状腺素蛋白心脏淀粉样变的血管功能和结构模式。一项比较研究。
Int J Cardiol. 2022 Sep 15;363:102-110. doi: 10.1016/j.ijcard.2022.06.035. Epub 2022 Jun 16.

引用本文的文献

1
Orthostatic hypotension after kidney transplantation in a patient with diabetic kidney disease: an underrecognized and therapeutic challenge.糖尿病肾病患者肾移植术后的体位性低血压:一个未被充分认识且具有治疗挑战性的问题。
CEN Case Rep. 2025 Sep 2. doi: 10.1007/s13730-025-01030-0.
2
Epidemiology of transthyretin (ATTR) amyloidosis: a systematic literature review.转甲状腺素蛋白(ATTR)淀粉样变性病的流行病学:一项系统文献综述
Orphanet J Rare Dis. 2025 Jan 16;20(1):29. doi: 10.1186/s13023-025-03547-0.
3
Associations of age-adjusted coefficient of variation of R-R intervals with autonomic and peripheral nerve function in non-elderly persons with diabetes.

本文引用的文献

1
Characteristics and natural history of early-stage cardiac transthyretin amyloidosis.早期心脏转甲状腺素蛋白淀粉样变性的特征与自然病史。
Eur Heart J. 2022 Jul 14;43(27):2622-2632. doi: 10.1093/eurheartj/ehac259.
2
Healthcare resource use associated with the diagnosis of transthyretin amyloidosis cardiomyopathy.与转甲状腺素蛋白淀粉样变心肌病诊断相关的医疗资源使用情况。
Health Sci Rep. 2022 Jan 6;5(1):e466. doi: 10.1002/hsr2.466. eCollection 2022 Mar.
3
Decline in renal function associated with cardiovascular autonomic neuropathy positively coordinated with proteinuria in patients with type 2 diabetes.
非老年糖尿病患者 R-R 间期校正后变异系数与自主神经和周围神经功能的相关性。
J Diabetes Investig. 2024 Feb;15(2):186-196. doi: 10.1111/jdi.14094. Epub 2023 Oct 16.
肾功能下降与心血管自主神经病变呈正相关,与 2 型糖尿病患者的蛋白尿相关。
J Diabetes Investig. 2022 Jan;13(1):102-111. doi: 10.1111/jdi.13625. Epub 2021 Jul 27.
4
Atrial Fibrillation in Transthyretin Cardiac Amyloidosis: Predictors, Prevalence, and Efficacy of Rhythm Control Strategies.转甲状腺素蛋白心脏淀粉样变相关性心房颤动:节律控制策略的预测因素、发生率和疗效。
JACC Clin Electrophysiol. 2020 Sep;6(9):1118-1127. doi: 10.1016/j.jacep.2020.04.019. Epub 2020 Jul 29.
5
JCS 2020 Guideline on Diagnosis and Treatment of Cardiac Amyloidosis.《日本循环学会2020年心脏淀粉样变性诊断与治疗指南》
Circ J. 2020 Aug 25;84(9):1610-1671. doi: 10.1253/circj.CJ-20-0110. Epub 2020 Aug 21.
6
Natural History and Disease Progression of Early Cardiac Amyloidosis Evaluated by Echocardiography.超声心动图评估早期心脏淀粉样变性的自然病史和疾病进展。
Am J Cardiol. 2020 Oct 15;133:126-133. doi: 10.1016/j.amjcard.2020.07.050. Epub 2020 Jul 28.
7
Autonomic dysfunction in cardiac amyloidosis assessed by heart rate variability and heart rate turbulence.心脏淀粉样变的自主神经功能障碍评估:心率变异性和心率震荡。
Ann Noninvasive Electrocardiol. 2020 Jul;25(4):e12749. doi: 10.1111/anec.12749. Epub 2020 Feb 21.
8
Association of decreased variation of coefficient R-R interval with ischemic colitis and small bowel obstruction.心率变异性的 RR 间期降低与缺血性结肠炎和小肠梗阻相关。
PLoS One. 2020 Feb 12;15(2):e0228117. doi: 10.1371/journal.pone.0228117. eCollection 2020.
9
Aortic Stenosis and Cardiac Amyloidosis: JACC Review Topic of the Week.主动脉瓣狭窄与心脏淀粉样变性:美国心脏病学会评论专题周报
J Am Coll Cardiol. 2019 Nov 26;74(21):2638-2651. doi: 10.1016/j.jacc.2019.09.056.
10
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019).日本高血压学会高血压管理指南(JSH 2019)。
Hypertens Res. 2019 Sep;42(9):1235-1481. doi: 10.1038/s41440-019-0284-9.